Wells Fargo & Company Lowers Crescent Capital BDC (NASDAQ:CCAP) Price Target to $18.00

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) had its price target decreased by equities researchers at Wells Fargo & Company from $19.00 to $18.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Wells Fargo & Company's price objective would indicate a potential downside of 1.48% from the stock's previous close.

Separately, Keefe, Bruyette & Woods boosted their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Monday, November 25th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.20.

Crescent Capital BDC Stock Up 0.2 %

Shares of Crescent Capital BDC stock traded up $0.04 on Friday, hitting $18.27. The company had a trading volume of 169,209 shares, compared to its average volume of 107,497. The stock has a 50-day moving average of $19.40 and a 200-day moving average of $18.89. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. Crescent Capital BDC has a twelve month low of $16.58 and a twelve month high of $20.19. The firm has a market capitalization of $677.12 million, a P/E ratio of 9.18 and a beta of 0.81.

Remove Ads

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). The firm had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. Research analysts predict that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Institutional Investors Weigh In On Crescent Capital BDC

Several hedge funds have recently bought and sold shares of CCAP. International Assets Investment Management LLC bought a new stake in Crescent Capital BDC in the third quarter valued at approximately $1,899,000. Hennion & Walsh Asset Management Inc. raised its stake in Crescent Capital BDC by 90.3% in the 3rd quarter. Hennion & Walsh Asset Management Inc. now owns 94,182 shares of the company's stock valued at $1,742,000 after acquiring an additional 44,700 shares during the period. Pettinga Financial Advisors LLC lifted its holdings in Crescent Capital BDC by 95.8% during the 3rd quarter. Pettinga Financial Advisors LLC now owns 29,017 shares of the company's stock valued at $537,000 after purchasing an additional 14,200 shares during the last quarter. Sun Life Financial Inc. lifted its holdings in Crescent Capital BDC by 20.7% during the 3rd quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company's stock valued at $41,187,000 after purchasing an additional 382,542 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in Crescent Capital BDC by 174.1% during the third quarter. Janney Montgomery Scott LLC now owns 47,264 shares of the company's stock worth $874,000 after purchasing an additional 30,018 shares during the period. 49.46% of the stock is currently owned by institutional investors and hedge funds.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.